Comparison of Glycemic Variability by Using Insulin Glargine and Insulin Degludec in Japanese Patients With Type 1 Diabetes, Monitored by Continuous Glucose Monitoring: A Preliminary Report

Journal of Endocrinology and Metabolism - Canada
doi 10.4021/jem193w
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elmer Press, Inc.

Related search

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Degludec in Patients With Type 2 Diabetes: A Randomized, Open-Label, Crossover Study Using Continuous Glucose Monitoring Profiles

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Effects of Insulin Degludec and Insulin Glargine on Day-To-Day Fasting Plasma Glucose Variability in Individuals With Type 1 Diabetes: A Multicentre, Randomised, Crossover Study

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons With Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL−1 and Glargine 100 U mL−1 in Japanese People With Type 1 Diabetes Mellitus: A Crossover Pilot Study

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

In Silico Head-To-Head Comparison of Insulin Glargine 300 U/Ml and Insulin Degludec 100 U/Ml in Type 1 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Similar Intrapatient Blood Glucose Variability With LY2963016 and Lantus® Insulin Glargine in Patients With Type 1 (T1D) or Type 2 Diabetes, Including a Japanese T1D Subpopulation

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

An Indirect Treatment Comparison of the Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine/Lixisenatide (iGlarLixi) in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin

Journal of Medical Economics
Health Policy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy